Emerging Diagnostics and Therapeutics for Invasive Fungal Infections

被引：12

作者：

Friedman, Daniel Z. P. ^{[1
]}

Schwartz, Ilan S. ^{[2
]}

机构：

[1] Univ Chicago, Sect Infect Dis & Global Hlth, 5841 South Maryland Ave,MC5065, Chicago, IL 60637 USA

[2] Duke Univ, Dept Med, Div Infect Dis, Sch Med, 315 Trent Dr, Durham, NC 27705 USA

来源：

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 03期

关键词：

Transplant; Mycology; Diagnosis; Diagnostic; Treatment; Antifungal; Olorofim; Fosmanogepix; GLUCAN SYNTHASE INHIBITOR; IN-VITRO ACTIVITY; PNEUMOCYSTIS-JIROVECII PNEUMONIA; LONG-ACTING ECHINOCANDIN; TIME PCR ASSAY; BRONCHOALVEOLAR LAVAGE; AZOLE RESISTANCE; ASPERGILLUS SPP; AMPHOTERICIN-B; MURINE MODEL;

D O I：

10.1016/j.idc.2023.05.001

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：593 / 616

页数：24

共 148 条

[1] Multiresistant Fusarium Pathogens on Plants and Humans: Solutions in (from) the Antifungal Pipeline? [J].

Al-Hatmi, Abdullah M. S. ;

de Hoog, G. Sybren ;

Meis, Jacques F. .

INFECTION AND DRUG RESISTANCE, 2019, 12 :3727-3737

[2] Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients [J].

Alanio, A. ;

Desoubeaux, G. ;

Sarfati, C. ;

Hamane, S. ;

Bergeron, A. ;

Azoulay, E. ;

Molina, J. M. ;

Derouin, F. ;

Menotti, J. .

CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (10) :1531-1537

[3] Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis [J].

Alkhazraji, Sondus ;

Gebremariam, Teclegiorgis ;

Alqarihi, Abdullah ;

Gu, Yiyou ;

Mamouei, Zeinab ;

Singh, Shakti ;

Wiederhold, Nathan P. ;

Shaw, Karen J. ;

Ibrahim, Ashraf S. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (03)

[4] Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST method [J].

Arendrup, M. C. ;

Meletiadis, J. ;

Zaragoza, O. ;

Jorgensen, K. M. ;

Marcos-Zambrano, L. J. ;

Kanioura, L. ;

Cuenca-Estrella, M. ;

Mouton, J. W. ;

Guinea, J. .

CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (11) :1200-1204

[5] In Vitro Activity of Ibrexafungerp (SCY-078) against Candida auris Isolates as Determined by EUCAST Methodology and Comparison with Activity against C. albicans and C. glabrata and with the Activities of Six Comparator Agents [J].

Arendrup, Maiken Cavling ;

Jorgensen, Karin Meinike ;

Hare, Rasmus Kroger ;

Chowdhary, Anuradha .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (03)

[6] Olorofim Susceptibility Testing of 1,423 Danish Mold Isolates Obtained in 2018-2019 Confirms Uniform and Broad-Spectrum Activity [J].

Astvad, Karen Marie Thyssen ;

Jorgensen, Karin Meinike ;

Hare, Rasmus Kroger ;

Datcu, Raluca ;

Arendrup, Maiken Cavling .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (01)

[7]

Atukunda M, 2022, OPEN FORUM INFECT DI, V9, P869

[8] A consensus conference to define the utility of advanced infectious disease diagnostics in solid organ transplant recipients [J].

Azar, Marwan M. ;

Turbett, Sarah ;

Gaston, David ;

Gitman, Melissa ;

Razonable, Raymund ;

Koo, Sophia ;

Hanson, Kimberly ;

Kotton, Camille ;

Silveira, Fernanda ;

Banach, David B. ;

Basu, Sankha S. ;

Bhaskaran, Archana ;

Danziger-Isakov, Lara ;

Bard, Jennifer Dien ;

Gandhi, Ronak ;

Hanisch, Benjamin ;

John, Teny M. ;

John, Audrey R. Odom ;

Letourneau, Alyssa R. ;

Me-Linh Luong ;

Maron, Gabriela ;

Miller, Steve ;

Prinzi, Andrea ;

Schwartz, Ilan ;

Simner, Patricia ;

Kumar, Deepali .

AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (12) :3150-3169

[9]

Azie NE, 2022, MYCOSES STUDY GROUP

[10]

Bader JC, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/aac.02614-17, 10.1128/AAC.02614-17]

← 1 2 3 4 5 6 7 8 9 10 →